Are all nations doing enough on SARS-CoV-2 sequencing? Clearly not

India has submitted only 20 genome sequences as compared to UK’s 93,544 since new variant surfaced

India starts COVID-19 vaccination drive; Modi calls doubts over vaccine ‘propaganda’

Prime Minsiter urges people to not drop caution even after being vaccinated 

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern

Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19

Serum Institute’s COVID-19 vaccine up for emergency approval

Civil society organisations urge Indian drug regulator to put vaccine trial data in public domain  

भारत में मिला कोरोनावायरस का नया स्ट्रेन, छह मरीजों की पुष्टि

अभी सरकार ने यह नहीं बताया है कि कोराेनावायरस का नया प्र�…

COVID-19: 6 UK returnees test positive for new strain, health ministry confirms

As many as 114 were found positive for SARS-CoV-2 after they returned from UK recently; genome sequencing results of remaining 108 are …

COVID-19 & the ‘Dharavi Model’: Reportage from the ground

Down To Earth hit the ground to see how the densely populated Dharavi was tackling the pandemic. This 3-part series delves into …

SC Mande: It is too early to say that the UK’s SARS-CoV-2 variant is not in India

India needs more labs dealing with extremely dangerous pathogens as well as trained human resources, says SC Mande, director-general of …

No integration in India’s disease data collection systems: Niti Aayog

White paper highlights several lacunae including shortage of human resources, occupational health, surveillance; suggests series of measures …

Don’t doubt India’s drug regulator on COVID-19 vaccines: Government

Weekly press meeting also releases details of COVID-19 vaccination; healthcare and frontline workers, seniors to be immunised on priority basis

Drug Controller General dodges query on COVID-19 vaccine adverse event

Govt webinar on clinical trials also skips questions on emergency authorisation, expert committees

Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial

Health secretary claims all procedures followed but refuses to divulge details

Delhi hasn’t done enough to contain COVID-19, Centre tells Supreme Court

Affidavit lists lack of testing, beds, contact-tracing

COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial

Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation

AMR week: Antimalaria drug resistance not alarming but growing fast, says WHO report

Three states in India’s North East reported resistance to commonly used drug against malaria

COVID-19 in India: Less than half the tests are RT-PCR

We are witnessing third spike in Delhi which is bigger than the second one: ICMR D-G

ICMR D-G is wrong; Kawasaki disease in children post-COVID has been reported in India

Shut down schools if positivity rate goes up to more than 5 per cent: IAP chief

कोविड-19 वैक्सीन किसे मिलेगी मुफ्त, अभी नहीं हुआ तय: केंद्रीय समूह

बिहार चुनाव में भाजपा ने अपने घोषणा में सबको कोविड-19 की म�…

COVID-19 vaccine freebies? Centre’s expert group says no decision yet

Wear masks as pollution can contribute to SARS-CoV-2 related mortality, warns ICMR

Convalescent plasma therapy may go off Indian protocol for COVID-19: ICMR

PM Modi urges citizens to follow precautions during upcoming festive season

COVID-19: All 4 repurposed drugs fail to show efficacy in WHO Solidarity Trial

The drugs failed to reduce mortality, hospitalisation stay and initiation of ventilation in admitted patients 

कोविड-19 वैक्सीन का सबसे बड़ा उत्पादक बन सकता है भारत: हॉटेज

ग्लोबल वैक्सीनेशन में भारत की भूमिका, इसकी चुनौतियां, व�…

India reports sharp decline in tuberculosis registration after COVID-19 lockdown

Extra 0.2-0.4 million global TB deaths could push world eight years back, says WHO report 

India can exert itself as one of the largest vaccine manufacturers during COVID-19: Vaccinologist Peter Hotez

Hotez talked to DTE on India’s role in global vaccination, its challenges on the home turf, anti-vax movement and vaccine diplomacy